Year: 2025

Alpha Modus Appoints Accomplished Executive Thomas Gallagher as Chief Revenue Officer to Drive Growth and Maximize Shareholder Value

Written by Customer Service on January 10, 2025. Posted in Public Companies.

CORNELIUS, N.C., Jan. 10, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (“Alpha Modus” or the “Company”), is pleased to announce the appointment of Thomas Gallagher as Chief Revenue Officer (CRO) of the Company. In this role, Mr. Gallagher will oversee global revenue generation strategies, scaling operations, and aligning the Company’s sales, marketing, and business development efforts to accelerate growth and deliver robust shareholder returns. Mr. Gallagher brings over two decades of proven leadership in driving revenue growth, strategic expansion, and operational excellence in competitive markets. Most recently, Mr. Gallagher served as Senior Vice President of Services and Solutions at Zones, where he spearheaded transformative strategies that significantly enhanced sales and operational efficiency. Prior...

Star Group Announces Completion of Acquisition

Written by Customer Service on January 10, 2025. Posted in Public Companies.

STAMFORD, Conn., Jan. 10, 2025 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE:SGU), a home energy distributor and services provider, today announced it has completed the acquisition related to a definitive purchase agreement previously announced in December, 2024. The transaction involved a home energy distributor located within the Company’s existing operating footprint; it was purchased for approximately $68 million before working capital adjustments. Additional terms were not disclosed. “I am pleased to announce the completion of this important acquisition, bringing another well-established home energy distributor under the Star umbrella,” said Jeff Woosnam, Star Group’s President and Chief Executive Officer. “As previously mentioned, the operations are expected to further strengthen...

ParaZero Receives MOD Approval for Marketing of the DefendAir, Its Counter-Drone Solution

Written by Customer Service on January 10, 2025. Posted in Public Companies.

TEL AVIV, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, announced today that it has received official approval from the Israeli Defense Export Controls Agency (DECA) under the Ministry of Defense (MOD) for the marketing of its cutting-edge Counter-Unmanned Aerial Systems (C-UAS) solution. This milestone marks a significant step in ParaZero’s efforts to expand its presence in the global defense and security markets. The company’s counter-drone system, The DefendAir by ParaZero, leverages ParaZero’s proprietary technology to intercept unauthorized or hostile drones, providing a robust last-line of defense for critical infrastructure, sensitive...

Silynxcom Estimates Record Annual Revenue of Approximately $9.2 million in 2024

Written by Customer Service on January 10, 2025. Posted in Earnings Releases And Operating Results.

Netanya, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced preliminary unaudited year-end financial results for the twelve months ended December 31, 2024. On a preliminary unaudited basis, Silynxcom is reporting a strong performance for 2024, highlighting accelerated operational and business growth including:Revenue estimated at $9.2 million in 2024, representing an increase of more than 20% compared to 2023; and Cash and cash equivalents as of December 31, 2024 totaled $3.2 million.“We are thrilled to announce record-breaking annual revenue of over $9.2 million for 2024, which we believe is a testament to our growing position in the defense market,” said Nir Klein,...

scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on January 10, 2025. Posted in Earnings Releases And Operating Results.

Preliminary unaudited fourth quarter 2024 net revenue expected to be approximately $12 million to $12.3 million, representing 99% growth over Q4 2023 at the mid-point of the range Fourth quarter 2024 Gross-to-net (GTN) discount expected to be in the range of 18% to 19% Preliminary unaudited full year 2024 net revenue expected to be approximately $36.2 million to $36.5 million, compared to $13.6 million for full year 2023 BURLINGTON, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced preliminary results for the fourth quarter and full year 2024, including fourth quarter 2024 net FUROSCIX revenue and unaudited cash and cash equivalents. “We continue to see FUROSCIX...

Hurco Reports Fourth Quarter and Full Year Results for Fiscal Year 2024

Written by Customer Service on January 10, 2025. Posted in Earnings Releases And Operating Results.

INDIANAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter and fiscal year ended October 31, 2024. Hurco recorded a net loss of $1,442,000, or $(0.23) per diluted share, for the fourth quarter of fiscal year 2024, which included a non-cash tax valuation allowance of $193,000 recorded in provision for income taxes, compared to net income of $2,422,000, or $0.36 per diluted share, for the corresponding period in fiscal year 2023. Hurco recorded a net loss of $16,608,000, or $(2.56) per diluted share, for fiscal year 2024, which included a non-cash tax valuation allowance of $8,590,000 recorded in provision for income taxes, compared to net income of $4,389,000, or $0.66 per diluted share, for fiscal year 2023. Sales and service fees for the fourth quarter...

LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers

Written by Customer Service on January 10, 2025. Posted in Public Companies.

LAVA-1266 is a potent and selective bispecific anti-CD123 Gammabody® First-in-human study enrolling adult patients with CD123-expressing AML or MDS Initial Phase 1 data read-out expected by year-end 2025UTRECHT, The Netherlands and PHILADELPHIA, Jan. 10, 2025 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, announced dosing of the first patient in the Phase 1, first-in-human study of the CD123-targeted Gammabody®, LAVA-1266, an investigational agent in development for the treatment of hematologic cancers including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). “We are pleased to announce the dosing of the first patient with LAVA-1266,...

Diana Shipping Inc. Announces Time Charter Contract for m/v New York With SwissMarine

Written by Customer Service on January 10, 2025. Posted in Public Companies.

ATHENS, Greece, Jan. 10, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with SwissMarine Pte. Ltd., Singapore, for one of its Capesize dry bulk vessels, the m/v New York. The gross charter rate is US$6,300 per day for the first trip of the charter period and US$17,600 per day for the balance period of the time charter, in each case minus a 5.00% commission paid to third parties, for a period until minimum January 15, 2026 up to maximum March 30, 2026. The charter is expected to commence on January 12, 2025. The “New York” is a 177,773 dwt Capesize dry bulk vessel built in 2010. The employment of...

Rail Vision Receives Purchase Order from One of the Leading Central America Freight Rail Operators

Written by Customer Service on January 10, 2025. Posted in Public Companies.

Ra’anana, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the forefront of revolutionizing railway safety and the data-related market, has received a purchase order for its MainLine product from one of the leading Central America freight operators. This purchase order will support a proof of concept (POC) aimed at demonstrating the MainLine’s advanced capabilities in enhancing rail safety and operational efficiency. The freight operator operates a vast fleet of locomotives across extensive rail networks. Known for its commitment to safety and technological modernization, the freight operator has invested significantly in upgrading its infrastructure, implementing efficient scheduling systems and adopting advanced safety protocols to minimize accidents and environmental...

CNB Financial Corporation and ESSA Bancorp, Inc. Announce Strategic Merger

Written by Customer Service on January 10, 2025. Posted in Mergers And Acquisitions.

CLEARFIELD, PA and STROUDSBURG, PA, Jan. 10, 2025 (GLOBE NEWSWIRE) — CNB Financial Corporation (Nasdaq: CCNE) (“CNB”), parent company of CNB Bank, and ESSA Bancorp, Inc. (Nasdaq: ESSA) (“ESSA”), parent company of ESSA Bank & Trust (“ESSA Bank”), jointly announced today that they have entered into a definitive agreement pursuant to which ESSA will merge with and into CNB, and ESSA Bank will merge with and into CNB Bank. The combined company is expected to have approximately $8 billion in total assets, $7 billion in total deposits, and $6 billion in total loans. The transaction consideration is all common stock and is presently valued at approximately $214 million in the aggregate, or approximately $21.10 per ESSA share, based upon the 10-day volume weighted average stock price (VWAP) of $24.69 for CNB common stock as of January...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals